Episode 09:  Engineered Multi-Specific Antibodies for Targeted Inhibition of Cancer Metastasis w/ Jamie Spangler episode artwork

EPISODE · Dec 10, 2019 · 21 MIN

Episode 09: Engineered Multi-Specific Antibodies for Targeted Inhibition of Cancer Metastasis w/ Jamie Spangler

from The Chain: Protein Engineering Podcast · host PepTalk

One of the greatest afflictions associated with cancer is its spread throughout the body and organs, known as metastasis. What if a therapeutic could be engineered to block the pathway of metastasis, thus blocking cancer’s progress? This is precisely the crux of Dr. Jamie Spangler’s research. Her group has, first, delineated cancer’s pathway, and, secondly, has engineered multi-specific antibodies that potently block metastasis. Dr. Spangler’s work combined with anti-cancer therapies shows exciting promise in the fight to overcome the ravages of cancer. In this podcast, Dr. Spangler discusses her work in considerable detail, and also describes her personal journey and transformation into protein science. 

Episode metadata supplied by the publisher feed · Published Dec 10, 2019

Embed this episode

Ready to play

Episode 09: Engineered Multi-Specific Antibodies for Targeted Inhibition of Cancer Metastasis w/ Jamie Spangler

0:00 21:58

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Chain: Protein Engineering Podcast?

This episode is 21 minutes long.

When was this The Chain: Protein Engineering Podcast episode published?

This episode was published on December 10, 2019.

Can I download this The Chain: Protein Engineering Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!